• 1
    Benard O. & Balasubramanian K.A. (1995) Effect of oxidized glutathione on intestinal mitochondria and brush border membrane. Int. J. Biochem. Cell Biol. 27,589595.
  • 2
    Ben-Shachar D., Zuk R., Glinka Y. (1995) Dopamine neurotoxicity : inhibition of mitochondrial respiration. J. Neurochem. 64,718723.
  • 3
    Berman S.B. & Hastings T.G. (1997) Inhibition of glutamate transport in synaptosomes by dopamine oxidation and reactive oxygen species. J. Neurochem. 69,11851195.
  • 4
    Berman S.B., Zigmond M.J., Hastings T.G. (1996) Modification of dopamine transporter function : effect of reactive oxygen species and dopamine. J. Neurochem. 67,593600.
  • 5
    Bernardi P. (1995) The permeability transition pore. History and perspectives of a cyclosporin A-sensitive mitochondrial channel. Prog. Cell Res. 5,119123.
  • 6
    Bernardi P., Vassanelli S., Veronese P., Raffaele C., Szabo I., Zoratti M. (1992) Modulation of the mitochondrial permeability transition pore : effect of protons and divalent cations. J. Biol. Chem. 267,29342939.
  • 7
    Bernheimer H., Birkmayer W., Hornykiewicz O., Jellinger K., Seitelberger F. (1973) Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J. Neurol. Sci. 20,415455.
  • 8
    Bowling A.C. & Beal M.F. (1995) Bioenergetic and oxidative stress in neurodegenerative diseases. Life Sci. 56,11511171.
  • 9
    Bradford M.A. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72,248254.DOI: 10.1006/abio.1976.9999
  • 10
    Brand M.D., Chien L., Ainscow E.D., Rolfe D.F.S., Porter R.K. (1994) The causes and functions of mitochondrial proton leak. Biochim. Biophys. Acta 1187,132139.
  • 11
    Broekemeier K.M., Dempsey M.E., Pfeiffer D.R. (1989) Cyclosporin A is a potent inhibitor of the inner membrane permeability transition in liver mitochondria. J. Biol. Chem. 264,78267830.
  • 12
    Brookes P.S., Land J.M., Clark J.B., Heales S.J.R. (1998) Peroxynitrite and brain mitochondria : evidence for increased proton leak. J. Neurochem. 70,21952202.
  • 13
    Cadenas E. (1995) Antioxidant and prooxidant functions of DT-diaphorase in quinone metabolism. Biochem. Pharmacol. 49,127140.
  • 14
    Cassarino D.S., Fall C.P., Smith T.S., Bennett J.P.J r. (1998) Pramipexole reduces reactive oxygen species production in vivo and in vitro and inhibits the mitochondrial permeability transition produced by the parkinsonian neurotoxin methylpyridinium ion. J. Neurochem. 71,295301.
  • 15
    Chance B. & Williams G.R. (1956) The respiratory chain and oxidative phosphorylation. Adv. Enzymol. 17,65134.
  • 16
    Chernyak B.V. & Bernardi P. (1996) The mitochondrial permeability transition pore is modulated by oxidative agents through both pyridine nucleotides and glutathione at two separate sites. Eur. J. Biochem.238,623630.
  • 17
    Cohen G., Farooqui R., Kesler N. (1997) Parkinson disease : a new link between monoamine oxidase and mitochondrial electron flow. Proc. Natl. Acad. Sci. USA 94,48904894.
  • 18
    Crompton M., Ellinger H., Costi A. (1988) Inhibition by cyclosporin A of a Ca2+-dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress. Biochem. J. 255,357360.
  • 19
    Cubbells J.F., Rayport S., Rajendran G., Sulzer D. (1994) Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress. J. Neurosci. 14,22602271.
  • 20
    Davey G.P. & Clark J.B. (1996) Threshold effects and control of oxidative phosphorylation in nonsynaptic rat brain mitochondria. J. Neurochem. 66,16171624.
  • 21
    Deckwerth T.L. & Johnson E.M. (1993) Temporal analysis of events associated with programmed cell death (apoptosis) of sympathetic neurons deprived of nerve growth factor. J. Cell Biol. 123,12071222.
  • 22
    Ellerby H.M., Martin S.J., Ellerby L.M., Naiem S.S., Rabizadeh S., Salvesen G.S., Casiano C.A., Cashman N.R., Green D.R., Bredesen D.E. (1997) Establishment of a cell-free system of neuronal apoptosis : comparison of premitochondrial, mitochondrial, and postmitochondrial phases. J. Neurosci. 17,61656178.
  • 23
    Fahn S. & Cohen G. (1992) The oxidant stress hypothesis in Parkinson’s disease : evidence supporting it. Ann. Neurol. 32,804812.
  • 24
    Filloux F. & Townsend J.J. (1993) Pre- and postsynaptic neurotoxic effects of dopamine demonstrated by intrastriatal injection. Exp. Neurol. 119,7988.
  • 25
    Fornstedt B., Brun A., Rosengren E., Carlsson A. (1989) The apparent autoxidation rate of catechols in dopamine-rich regions of human brains increases with the degree of depigmentation of substantia nigra. J. Neural Transm. 1,279295.
  • 26
    Fornstedt B., Bergh I., Rosengren E., Carlsson A. (1990) An improved HPLC-electrochemical detection method for measuring brain levels of 5-S-cysteinyldopamine, 5-S-cysteinyl-3,4-dihydroxyphenylalanine, and 5-S-cysteinyl-3,4-dihydroxyphenylacetic acid. J. Neurochem. 54,578586.
  • 27
    Fournier N., Ducet G., Crevat A. (1987) Action of cyclosporine on mitochondrial calcium fluxes. J. Bioenerg. Biomembr. 19,297303.
  • 28
    Friberg H., Ferrand-Drake M., Bengtsson F., Halestrap A.P., Wieloch T. (1998) Cyclosporin A, but not FK506, protects mitochondria and neurons against hypoglycemic damage and implicates the mitochondrial permeability transition in cell death. J. Neurosci. 18,51515159.
  • 29
    Graham D.G. (1978) Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol. Pharmacol. 14,633643.
  • 30
    Greenawalt J.W. & Schnaitman C. (1970) An appraisal of the use of monoamine oxidase as an enzyme marker for the outer membrane of rat liver mitochondria. J. Cell Biol. 46,173179.
  • 31
    Gunter T.E. & Pfeiffer D.R. (1990) Mechanisms by which mitochondria transport calcium. Am. J. Physiol. 258,C755C786.
  • 32
    Hafner R.P., Brown G.C., Brand M.D. (1990) Analysis of the control of respiration rate, phosphorylation rate, proton leak rate and protonmotive force in isolated mitochondria using the “topdown” approach. Eur. J. Biochem. 188,313319.
  • 33
    Halliwell B. (1992) Reactive oxygen species and the central nervous system. J. Neurochem. 59,16091623.
  • 34
    Hastings T.G. (1995) Enzymatic oxidation of dopamine : the role of prostaglandin H synthase. J. Neurochem. 64,919924.
  • 35
    Hastings T.G. & Zigmond M.J. (1994) Identification of catechol-protein conjugates in neostriatal slices incubated with [3H]dopamine : impact of ascorbic acid and glutathione. J. Neurochem. 63,11261132.
  • 36
    Hastings T.G., Lewis D., Zigmond M.J. (1996) Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. Proc. Natl. Acad. Sci. USA 93,19561961.
  • 37
    Henry T.R. & Wallace K.B. (1995) Differential mechanisms of induction of the mitochondrial permeability transition by quinones of varying chemical reactivities. Toxicol. Appl. Pharmacol. 134,195203.
  • 38
    Henry T.R., Solem L.E., Wallace K.B. (1995) Channel-specific induction of the cyclosporine A-sensitive mitochondrial permeability transition by menadione. J. Toxicol. Environ. Health 45,489504.
  • 39
    Kenney W.C. (1975) The reaction of N-ethylmaleimide at the active site of succinate dehydrogenase. J. Biol. Chem. 250,30893094.
  • 40
    Koga S., Nakano M., Tero-Kuboto S. (1992) Generation of superoxide during the enzymatic action of tyrosinase. Arch. Biochem. Biophys. 292,570575.
  • 41
    Kuhn D.M. & Arthur R. (1998) Dopamine inactivates tryptophan hydroxylase and forms a redox-cycling quinoprotein—possible endogenous toxin to serotonin neurons. J. Neurosci. 18,71117117.
  • 42
    LaVoie M.J. & Hastings T.G. (1999) Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine : evidence against a role for extracellular dopamine. J. Neurosci. 19,14841491.
  • 43
    Liu X., Kim C.N., Yang J., Jemmerson R., Wang X. (1996) Induction of apoptotic program in cell-free extracts : requirement for dATP and cytochrome c. Cell 86,147157.
  • 44
    Maker H.S., Weiss C., Silides D.J., Cohen G. (1981) Coupling of dopamine oxidation (monoamine oxidase activity) to glutathione oxidation via the generation of hydrogen peroxide in rat brain homogenates. J. Neurochem. 36,589593.
  • 45
    Mann V.M., Cooper J.M., Krige D., Daniel S.E., Schapira A.H., Marsden C.D. (1992) Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson’s disease. Brain 115,333342.
  • 46
    Martin M.A., Molina J.A., Jimenez-Jimenez F.J., Benito-Leon J., Orti-Pareja M., Campos Y., Arenas J. (1996) Respiratory chain enzyme activities in isolated mitochondria of lymphocytes from untreated Parkinson’s disease patients. Neurology 46,13431346.
  • 47
    Michel P.P. & Hefti F. (1990) Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture. J. Neurosci. Res. 26,428435.
  • 48
    Morikawa N., Nakagawa-Hattori Y., Mizuno Y. (1996) Effect of dopamine, dimethoxyphenylethylamine, papaverine, and related compounds on mitochondrial respiration and complex I activity. J. Neurochem. 66,11741181.
  • 49
    Nieminen A., Petrie T.G., LeMasters J.J., Selman W.R. (1996) Cyclosporin A delays mitochondrial depolarization induced by N-methyl-D-aspartate in cortical neurons : evidence of the mitochondrial permeability transition. Neuroscience 75,993997.
  • 50
    Ouyang Y.B., Kuroda S., Kristian T., Siesjö B.K. (1997) Release of mitochondrial aspartate aminotransferase (MAST) following transient focal cerebral ischemia suggests the opening of a mitochondrial permeability transition pore. Neurosci. Res. Commun. 20,167173.
  • 51
    Packer M.A., Miesel R., Murphy M.P. (1996) Exposure to the parkinsonian neurotoxin 1-methyl-4-phenylpyridinium (MPP+) and nitric oxide simultaneously causes cyclosporin A-sensitive mitochondrial calcium efflux and depolarisation. Biochem. Pharmacol. 51,267273.
  • 52
    Palmeira C.M. & Wallace K.B. (1997) Benzoquinone inhibits the voltage-dependent induction of the mitochondrial permeability transition caused by redox-cycling naphthoquinones. Toxicol. Appl. Pharmacol. 143,338347.DOI: 10.1006/taap.1996.8099
  • 53
    Parker W.D., Boyson S.J., Parks J.K. (1989) Abnormalities of the electron transport chain in idiopathic Parkinson’s disease. Ann. Neurol. 26,719723.
  • 54
    Petit P.X., LeCoeur H., Zorn E., Duguet C., Mignotte B., Gougeon M.L. (1995) Alterations of mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis. J. Cell Biol. 130,157167.
  • 55
    Petronilli V., Costantini P., Scorrano L., Colonna R., Passamonti S., Bernardi P. (1994) The voltage sensor of the mitochondrial permeability transition pore is turned by the oxidation-reduction state of vicinal thiols : increase of the gating potential by oxidants and its reversal by reducing agents. J. Biol. Chem. 269,1663816642.
  • 56
    Przedborski S., Jackson-Lewis V., Muthane U., Jiang H., Ferreira M., Naini A.B., Fahn S. (1993) Chronic levodopa administration alters cerebral mitochondrial respiratory chain activity. Ann. Neurol. 34,715723.
  • 57
    Radi R., Bechman J.S., Bush K.M., Freeman B.A. (1991) Peroxynitrite oxidation of sulfhydryls : the cytotoxic potential of superoxide and nitric oxide. J. Biol. Chem. 206,42444250.
  • 58
    Rosenthal R.E., Hamud F., Fiskum G., Varghese P.J., Sharpe S. (1987) Cerebral ischemia and reperfusion : prevention of brain mitochondrial injury by lidoflazine. J. Cereb. Blood Flow Metab. 7,752758.
  • 59
    Savage M.K., Jones D.P., Reed D.J. (1991) Calcium- and phosphate-dependent release and loading of glutathione by liver mitochondria. Arch. Biochem. Biophys. 290,5156.
  • 60
    Schapira A.H.V., Cooper J.M., Dexter D., Clark J.B., Jenner P., Marsden C.D. (1990 a) Mitochondrial complex I deficiency in Parkinson’s disease. J. Neurochem. 54,823827.
  • 61
    Schapira A.H.V., Mann V.M., Cooper J.M., Dexter D., Daniel S.E., Jenner P., Clark J.B., Marsden C.D. (1990 b) Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson’s disease. J. Neurochem. 55,21422145.
  • 62
    Schinder A.F., Olson E.C., Spitzer N.C., Montal M. (1996) Mitochondrial dysfunction is a primary event in glutamate neurotoxicity. J. Neurosci. 16,61256133.
  • 63
    Sheehan J.P., Swerdlow R.H., Parker W.D., Miller S.W., Davis R.E., Tuttle J.B. (1997) Altered calcium homeostasis in cells transformed by mitochondria from individuals with Parkinson’s disease. J. Neurochem. 68,12211233.
  • 64
    Shoffner J.M., Watts R.L., Juncos J.L., Torroni A., Wallace D.C. (1991) Mitochondrial oxidative phosphorylation defects in Parkinson’s disease. Ann. Neurol. 30,332339.
  • 65
    Spencer J.P.E., Jenner P., Daniel S.E., Lees A.J., Marsden D.C., Halliwell B. (1998) Conjugates of catecholamines with cysteine and GSH in Parkinson’s disease : possible mechanisms of formation involving reactive oxygen species. J. Neurochem. 71,21122122.
  • 66
    Stephans S.E. & Yamamoto B.K. (1994) Methamphetamine-induced neurotoxicity : roles for glutamate and dopamine efflux. Synapse 17,203209.
  • 67
    Sulzer D., Chen T., Lau Y.Y., Kristensen H., Rayport S., Ewing A. (1995) Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. J. Neurosci. 15,41024108.
  • 68
    Susin S.A., Zamzami N., Castedo M., Hirsch T., Marchetti P., Macho A., Daugas E., Geuskens M., Kroemer G. (1996) Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J. Exp. Med. 184,13311341.
  • 69
    Tomita Y., Hariu A., Kato C., Seiji M. (1984) Radical production during tyrosinase reaction, dopa-melanin formation, and photoirradiation of dopa-melanin. J. Invest. Dermatol. 82,573576.
  • 70
    Tse D.C.S., McCreery R.L., Adams R.N. (1976) Potential oxidative pathways of brain catecholamines. J. Med. Chem. 19,3740.
  • 71
    Uchino H., Elmér E., Uchino K., Lindvall O., Siesjö B.K. (1995) Cyclosporin A dramatically ameliorates CA1 hippocampal damage following transient forebrain ischemia in the rat. Acta Physiol. Scand. 155,469471.
  • 72
    Valle V.G.R., Fagian M.M., Parentoni L.S., Meinicke A.R., Vercesi A.E. (1993) The participation of reactive oxygen species and protein thiols in the mechanism of mitochondrial inner membrane permeabilization by calcium plus prooxidants. Arch. Biochem. Biophys. 307,17.
  • 73
    Vayssiére J., Petit P.X., Risler Y., Mignotte B. (1994) Commitment to apoptosis is associated with changes in mitochondrial biogenesis and activity in cell lines conditionally immortalized with simian virus 40. Proc. Natl. Acad. Sci. USA 91,1175211756.
  • 74
    White R.J. & Reynolds I.J. (1996) Mitochondrial depolarization in glutamate-stimulated neurons : an early signal specific to excitotoxin exposure. J. Neurosci. 16,56885697.
  • 75
    Xu Y.M., Stokes A.H., Roskoski R., Vrana K.E. (1998) Dopamine, in the presence of tyrosinase, covalently modifies and inactivates tyrosine hydroxylase. J. Neurosci. Res. 54,691697.
  • 76
    Yagi T. & Hatefi Y. (1987) Thiols in oxidative phosphorylation : thiols in the F0 of ATP synthase essential for ATPase activity. Arch. Biochem. Biophys. 254,102109.
  • 77
    Zamzami N., Marchetti P., Castedo M., Zanin C., Vayssiere J., Petit P.X., Kroemer G. (1995 a) Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J. Exp. Med. 181,16611672.
  • 78
    Zamzami N., Marchetti P., Castedo M., Decaudin D., Macho A., Hirsch T., Susin S.A., Petit P.X., Mignotte B., Kroemer G. (1995 b) Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J. Exp. Med. 182,367377.
  • 79
    Zamzami N., Susin S.A., Marchetti P., Hirsch T., Gómez-Monterrey I., Castedo M., Kroemer G. (1996) Mitochondrial control of nuclear apoptosis. J. Exp. Med. 183,15331544.
  • 80
    Zhang Y., Marcillat O., Giulivi C., Ernster L., Davies K.J.A. (1990) The oxidative inactivation of mitochondrial electron transport chain components and ATPase. J. Biol. Chem. 265,1633016336.